Hhlr Advisors, Ltd. Aligos Therapeutics, Inc. Call Options Transaction History
Hhlr Advisors, Ltd.
- $3.87 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALGS
# of Institutions
32Shares Held
37.7MCall Options Held
1.4KPut Options Held
300-
Baker Bros. Advisors LP New York, NY2.08MShares$39.2 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA1.65MShares$31.2 Million0.07% of portfolio
-
Opaleye Management Inc. Boston, MA1.26MShares$23.8 Million0.11% of portfolio
-
Bank Of America Corp Charlotte, NC816KShares$15.4 Million0.0% of portfolio
-
Newtyn Management, LLC New York, NY719KShares$13.6 Million0.05% of portfolio
About Aligos Therapeutics, Inc.
- Ticker ALGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,717,000
- Market Cap $751M
- Description
- Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...